Why Travere Therapeutics (TVTX) Is Up 18.9% After FDA Eases FILSPARI Oversight And Delays Adcom

Travere Therapeutics recently reached a new 52-week high after investors reacted to regulatory updates for its rare kidney disease therapy FILSPARI, including the removal of an FDA advisory committee ...

DaVita (DVA) share price

Get the live share price of DaVita HealthCare Partners Inc (DVA), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow

MLYS, LYEL, NKTR and INSM rise more than 50% in 2025 as clinical wins, FDA approvals and M&A deals revive sector momentum heading into 2026.

AstraZeneca (AZN) share price

Get the live share price of AstraZeneca PLC ADR (AZN), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

MannKind Shares FUROSCIX Business Updates

FDA approves FUROSCIX- for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 ...

Renalytix PLC ADR

Renalytix PLC ADR advanced stock charts by Barron's. View RNLXD historical stock data and compare to other stocks, and exchanges.

DaVita: Balancing a Kidney Diet: Optimizing Nutrition Through Personalization

NORTHAMPTON, MA / ACCESS Newswire / December 22, 2025 / DaVita:For individuals managing chronic kidney disease (CKD), dietary ...